Boothbay Fund Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $751K | Sell |
1,528
-1,308
| -46% | -$710K | 0.01% | 1108 |
|
|
2025
Q4 | $1.64M | Sell |
2,836
-9,600
| -77% | -$5.43M | 0.02% | 637 |
|
|
2025
Q3 | $6.03M | Buy |
12,436
+8,963
| +258% | +$4.17M | 0.09% | 260 |
|
|
2025
Q2 | $1.41M | Sell |
3,473
-2,269
| -40% | -$949K | 0.03% | 588 |
|
|
2025
Q1 | $2.86M | Sell |
5,742
-21,008
| -79% | -$11.4M | 0.08% | 349 |
|
|
2024
Q4 | $13.9M | Buy |
26,750
+12,435
| +87% | +$6.84M | 0.34% | 50 |
|
|
2024
Q3 | $8.85M | Buy |
14,315
+3,785
| +36% | +$2.24M | 0.2% | 121 |
|
|
2024
Q2 | $5.82M | Buy |
10,530
+5,149
| +96% | +$2.95M | 0.14% | 184 |
|
|
2024
Q1 | $3.13M | Sell |
5,381
-20,498
| -79% | -$11.5M | 0.06% | 358 |
|
|
2023
Q4 | $13.7M | Buy |
+25,879
| New | +$12.5M | 0.35% | 36 |
|
|
2023
Q3 | – | Sell |
-8,699
| Closed | -$4.54M | – | 2082 |
|
|
2023
Q2 | $4.54M | Sell |
8,699
-4,204
| -33% | -$2.27M | 0.1% | 244 |
|
|
2023
Q1 | $7.44M | Sell |
12,903
-2,875
| -18% | -$1.62M | 0.15% | 133 |
|
|
2022
Q4 | $8.69M | Buy |
15,778
+7,342
| +87% | +$3.89M | 0.2% | 86 |
|
|
2022
Q3 | $4.28M | Buy |
8,436
+2,711
| +47% | +$1.52M | 0.11% | 240 |
|
|
2022
Q2 | $3.11M | Buy |
5,725
+4,768
| +498% | +$2.62M | 0.08% | 369 |
|
|
2022
Q1 | $565K | Sell |
957
-10,463
| -92% | -$6.01M | 0.01% | 1227 |
|
|
2021
Q4 | $7.62M | Buy |
11,420
+7,679
| +205% | +$4.79M | 0.18% | 119 |
|
|
2021
Q3 | $2.14M | Sell |
3,741
-1,646
| -31% | -$903K | 0.06% | 424 |
|
|
2021
Q2 | $2.72M | Buy |
+5,387
| New | +$2.54M | 0.09% | 276 |
|
|
2020
Q4 | – | Sell |
-2,415
| Closed | -$1.07M | – | 1415 |
|
|
2020
Q3 | $1.07M | Sell |
2,415
-155
| -6% | -$64K | 0.06% | 405 |
|
|
2020
Q2 | $931K | Sell |
2,570
-2,954
| -53% | -$990K | 0.06% | 410 |
|
|
2020
Q1 | $1.57M | Buy |
5,524
+1,024
| +23% | +$323K | 0.13% | 191 |
|
|
2019
Q4 | $1.46M | Sell |
4,500
-203
| -4% | -$61.6K | 0.13% | 223 |
|
|
2019
Q3 | $1.37M | Sell |
4,703
-876
| -16% | -$251K | 0.13% | 228 |
|
|
2019
Q2 | $1.64M | Buy |
5,579
+541
| +11% | +$149K | 0.15% | 173 |
|
|
2019
Q1 | $1.38M | Sell |
5,038
-667
| -12% | -$166K | 0.13% | 170 |
|
|
2018
Q4 | $1.28M | Buy |
5,705
+684
| +14% | +$160K | 0.19% | 109 |
|
|
2018
Q3 | $1.23M | Buy |
5,021
+275
| +6% | +$63.3K | 0.12% | 159 |
|
|
2018
Q2 | $983K | Buy |
+4,746
| New | +$1.01M | 0.09% | 193 |
|
|
2017
Q2 | – | Sell |
-2,706
| Closed | -$416K | – | 841 |
|
|
2017
Q1 | $416K | Buy |
+2,706
| New | +$414K | 0.08% | 300 |
|
|
2015
Q1 | – | Sell |
-2,034
| Closed | -$255K | – | 414 |
|
|
2014
Q4 | $255K | Buy |
+2,034
| New | +$247K | 0.2% | 188 |
|
Other funds holding TMO
VCM
Boothbay Fund Management's TMO Position: Q1 2026 in Review
Boothbay Fund Management reduced its Thermo Fisher Scientific (TMO) stake by 46% in Q1 2026, selling an estimated $710K and leaving 1,528 shares worth $751K. The position accounts for 0.01% of the portfolio, ranked #1108.
Boothbay Fund Management first reported a position in TMO in Q4 2014 and has held it in 31 quarters since. The position peaked at $13.9M in Q4 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Boothbay Fund Management held 1,528 shares of Thermo Fisher Scientific worth $751K as of Q1 2026.
- Boothbay Fund Management sold 1,308 Thermo Fisher Scientific shares in Q1 2026, an estimated $710K.
- Thermo Fisher Scientific made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1108 holding.
- Boothbay Fund Management first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 31 quarters since.
- Boothbay Fund Management's Thermo Fisher Scientific position peaked at $13.9M in Q4 2024.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.